Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology - Van de Werf, F; Bergmann, SR; Fox, KA; De Geest, H; Hoyng, CF; Sobel, BE; Collen, D (Circulation, 1984)